Courtesy of Benzinga.
Thursday, February 23, 2012
This is your Benzinga news summary and trader’s outlook covering headlines from overnight and today’s pre-market session.
Benzinga’s Top News
- Kohls (NYSE: KSS) Reports Q4 EPS $1.81 vs $1.80 Est; Revenues $6.00B vs $6.06B Est
- OfficeMax (NYSE: OMX) Reports Q4 EPS $0.17 vs $0.14 Est; Revenues $1.84B vs $1.80B Est
- Mylan (NYSE: MYL) Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
- FDA Accepts Impax Pharmaceuticals (NASDAQ: IPXL) NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson’s Disease
Domestic Pre-Market Trading
- U.S. Equity Markets trade higher as Dow futures trade up about 17 points.
- U.S. Dollar trades about 0.34% lower.
To see more pre-market news, click here.
Overseas Trading
- European markets are lower in afternoon mixed. Britain’s FTSE 100 added 0.21%, Germany’s DAX slid 0.44% and France’s CAC 40 fell 0.06% on the session.
- Asian stocks ended the session mixed as well. China’s Shanghai added 0.28%, Japan’s Nikkei 225 advanced 0.44%, and Hong Kong’s Hang Seng slid 0.78%.
To see more overseas news, click here.
Upgrades/Downgrades
- Deutsche Bank Upgrades Kellogg (NYSE: K) from Hold to Buy, Raises PT from $51 to $57
- Morgan Stanley Upgrades Level 3 Communications (NASDAQ: LVLT) from Equal-weight to Overweight, Maintains PT at $31
To see more of today’s upgrades, click here.
- Credit Suisse Downgrades Canadian Imperial Bank (NYSE: CM) from Outperform to Neutral, Maintains PT at $81
- Collins Stewart Downgrades Human Genome Sciences (NASDAQ: HGSI) from Buy to Neutral, Lowers PT from $17 to $10
To see more of today’s downgrades, click here.
On the Economic Calendar
- Initial and Continuing Jobless Claims are set to report at 8:30 a.m. ET
- House Price Index is due at 10:00 a.m.
To see more economic news, click here
Earnings
- Kohls (NYSE: KSS) Reports Q4 EPS $1.81 vs $1.80 Est; Revenues $6.00B vs $6.06B Est
- OfficeMax (NYSE: OMX) Reports Q4 EPS $0.17 vs $0.14 Est; Revenues $1.84B vs $1.80B Est
- MetroPCS Communications (NYSE: PCS) Reports Q4 EPS $0.25 vs $0.16 Est; Revenues $1.24B vs $1.24B Est
- Hormel Foods (NYSE: HRL) Reports Q1 EPS $0.48 vs $0.48 Est; Revenues $2.04B vs $2.02B Est
To see more earnings announcements, click here.
Corporate News
- Darden Restaurants (NYSE: DRI) Announces Projected Q3 EPS $1.23-1.25 vs $1.19 Est
- Mylan (NYSE: MYL) Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
- FDA Accepts Impax Pharmaceuticals (NASDAQ: IPXL) NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson’s Disease
To see more corporate news, click here.
Commodities
- Precious metals are trading higher, with gold posting early gains of about 0.37%
- Energy futures are trading higher, with crude oil posting early gains of about 0.18%
- Natural Gas futures are higher by about 0.68% and copper is trading lower by about 0.33%
To see more commodities news, click here.
Benzinga’s Morning Radar
Technical Levels for Futures and Forex
| Name | Resistance-2 | Resistance-1 | Mid Pivot | Support-1 | Support-2 |
| E-Mini S&P 500 | 1368 | 1362 | 1357 | 1351 | 1346 |
| Gold | 1803 | 1790 | 1770 | 1757 | 1737 |
| Crude | 107.20 | 106.58 | 106.09 | 105.47 | 104.98 |
| Natural Gas | 2.75 | 2.70 | 2.61 | 2.56 | 2.48 |
| EUR/USD | 1.3300 | 1.3271 | 1.3241 | 1.3216 | 1.3186 |
| US Dollar Index | 79.65 | 79.46 | 79.27 | 79.07 | 78.88 |
Subscribe Click here to subscribe to this newsletter. Receive it daily to your inbox!
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.
